Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hopefully they do, the impressions say other wise. Too many companies out there trying to get to the finish line too. One thing to keep in mind, this has been in the works for over 40 years , so the info has been out for awhile that can be reversed engineered at this point. It is a race that is for sure. They also are not the only A/I company yes they are building a data base for sure but if anyone thinks they have the A/I side locked up they are kidding themselves. There is a few A/I companies doing the same and are trading alot higher than ENZC is. I am in on this for 4m shares I do want this to succeed but we all can't ignore what has been told to us for almost 3 years and what has happened based on their words and timelines they taunted. Yes Bio's take time, it was what they told and displayed as being further along than they actually were that is driving the questions we hear today nothing more nothing less. Nothing new today happening going golfing have a great day.GLTA
I understand what they have they want to bring to humanity , my question is why no big investors wants to bring it to market . 100B would be a motivator for the ones who have deep pockets. Lets not forget Intel and Samsung why havent one or both carry Enzolytics across the finish line. Both CEO have stated they wanted this to happen, so again 450m to either company is nothing. Not bashing , just alot of unanswered questions after all the statements made by Enzolytics over the 2.5 years. GLTA
I guess the biggest question is with over 20 years of testing, lawsuits with Fauci , why isn't Enzolytics door being beat down to get to this technology and they have to go thru a SPAC for a 450m payday when they posted the worth over 10 years would be 100B? Hopefully it proves out this time, I am hoping just have to look at facts and what has been delivered so far. GLTA
Gotcha ya , I know I wouldn't vote to extend it unless I was to see hard facts of results. The 110m that Barry K raised 2 years ago has done nothing for the people who bought in but just sitting with no follow thru. First they have to clean up NASDAQ or this deal means nothing to Enzolytics.
Not sure where you got that date , here is the last posting from SAGA . That date might be a NASDAQ date if granted to clear their issues up.
https://www.globenewswire.com/news-release/2023/09/15/2744256/0/en/SAGALIAM-ACQUISITION-CORP-ANNOUNCES-EXECUTION-OF-DEFINITIVE-BUSINESS-COMBINATION-AGREEMENT-AND-RECEIPT-OF-NASDAQ-LISTING-DELINQUENCY-LETTER.html
https://finance.yahoo.com/news/enzolytics-announces-signing-business-combination-120000361.html
I agree with you I hope it doesnt go thru , I never said the doctor was responsible. SAGA is responsible for the clean up
How they said it would be done it would trade under SAGA with a new sub company under their ticker sign. They have to get things cleaned up or they are going to be delisted. That means that the deal then would not boost the 2 companies into Nasdaq. If the deal is not inked by the 23rd of this month the SPAC will nolonger be workable due to how it was created 2 years ago and investors will beturned the money, unless they have a vote to extend the SPAC. thats the 450m question. Not arguing with you just pointing out the facts they have to clean up the business end , or they are no better position than Enzolytics is currently.
Under the terms of the agreement, BGEN and VIRO will become wholly owned subsidiaries of Sagaliam, currently trading on NASDAQ, and will adopt SAGA Scientific Holdings Corp. as the corporate name.
https://finance.yahoo.com/news/enzolytics-inc-announces-execution-non-110000829.html
Doesnt work like that to run from your isuues with SEC and or NASDAQ , GLTA
According to the SEC, companies can change their names, but the process is not as simple as it sounds. The SEC requires that any proposed name change be reviewed and approved by them 12.
The SEC has a set of naming standards that must be followed when changing a company’s name. If the new name does not meet these standards, it may be modified by the system 1.
It is important to note that changing a company’s name does not necessarily mean that it will avoid any issues with the SEC. If a company is under investigation or has been charged with a violation, changing its name will not make the issue go away 3.
In conclusion, while companies can change their names, it is not a guaranteed solution to avoid issues with the SEC. It is best to consult with legal counsel before making any decisions.
A company can change its name for various reasons, such as rebranding or to better reflect its products and services 1. However, changing a company’s name to avoid Nasdaq issues is not a common practice. If a company is facing issues with Nasdaq, it is likely due to non-compliance with Nasdaq’s listing requirements 2.
If a company changes its name without addressing the underlying issues, it will not solve the problem. The new name will not change the company’s financial performance or compliance status 1.
Moreover, if a company changes its name to avoid legal issues, it may be subject to legal action. For instance, if a company changes its name to evade a lawsuit, it may be sued for fraudulent conveyance 3.
In summary, changing a company’s name to avoid Nasdaq issues is not an effective solution. It is advisable for companies to address the underlying issues and comply with Nasdaq’s listing requirements.
Goldman Small Cap Research is a capital markets company based out of 1498 Reisterstown Rd, Pikesville, Maryland, United States. They provide research reports, blogs, and newsletters on publicly-traded emerging growth stocks, microcaps, and penny stocks. However, it’s important to note that in the past, the Securities and Exchange Commission (SEC) charged Goldman Small Cap Research and its owner for failing to disclose compensation related to promoting securities on social media12. As with any investment-related information, it’s advisable to exercise due diligence and consider multiple sources before making any decisions. 📈🔍
Rob Goldman
Goldman Small Cap Research is run by a clever bugger, called Rob Goldman, who writes sponsored small-cap and micro-cap stock reports and the like. Neither Rob (what a propitious name) nor Goldman Small Cap Research is a registered investment adviser or associated with the Financial Industry Regulatory Authority in any capacity.
It all is good info , hopefully it is happens .
Clone 7 has been around maybe not for Enzolytics but clone 7 has been used in other applications , not saying as HIV ect as Enzolytics but different forms . Don't get me wrong I like the news, just want the follow thru , their was great info and news on Enzolytics web page too. Date backs to 2010 as source listed below. GLTA
https://www.biolegend.com/en-us/products/apc-anti-human-cd133-antibody-13915?GroupID=BLG15840
https://www.sigmaaldrich.com/US/en/product/sigma/zms1040
https://pubmed.ncbi.nlm.nih.gov/20674577/ this is from 2010
Why do you think that , a few of us have done alot of DD, have been around and all had the same reasons they invested here , it was due to the PRs that mislead timeframes. It was believable due to the fact that Harryand family has been working on this for 40 years , Fauci was ruled by a court of law that he could not claim it . So sorry if you think we are bitchin we are comparing the facts and it seems noone can disprove the facts if you can please provide it. For many they bought in at a much higher level and have a good amount invested due to the same information and PRs so if they want to voice their disgust with the delays, lack of information on trials, and lack of followup to shareholders as the COO is trolling on ( X ) that is their right to. Just as it is yours to ignore any of us. GLTA
I understand what u asked , that is why I said it can be looked up so you get the correct filing date for each patent since they have multiple filings and various dates no problem Govt agency who doesnt know how that works ,
I think you will not be alone if we have a run like that or even half GLTA
I agree I and like MP and others are saying , the audits are the key to everything. If they had to disclose what they have been doing , working with, funding ,and or anything else CC would not be able to move as fluently as he can now. Something changed because the 2 year were finally done but remain non audits , they were on their way then was it the past catching up with Harry and Enzc. I don't think we will know. Just weird they finally got to the top step and then radio silence, and miststeps on the rest of the follow thru . GLTA
Yes we agree , if law suits were in place they have to live with it. I havent gone back to see when the lawsuit were filed . not worried about it , now it is what it is
Do you recall what I am talking about ? He stated that debit would be absord by them which I thought was alittle crazy for them to do, maybe Steve S got paid well for doing it who knows we haven't seen or heard about them since it happened . Remember he and the company were to be building the network across the pond, so what has that yielded.
Yes it can be transfered to a specific company under a parent company. In the 70s a company called HK Porter did it to a company called Tidewater supply company which caused TW to go out of business ending liablity to HKP . Same principle when one wants to show a profit in one branch and a loss in another. It is all on how it was setup which we don't know and maybe that is why CC thought he had protected ENZC but then it was the handshake deals that came back and got him as we are seeing, no proof of what Harry did or didn't give away.
Sorry I put all this out , yes you are right about value , but what is value as of right now. .04 while SAGA is 11.+ for what
Parent subsidiary liability refers to the situation where a parent corporation can be held liable for the actions of its subsidiaries. However, determining liability depends on several considerations:
Relationship Between a Company and Its Subsidiary:
The extent of stock ownership by the parent company.
Whether the corporation acquired a new company or purchased existing shares in a company.
The level of independence maintained by the subsidiary.
The intentions of the parent company regarding control over board members, voting, and regulations.
Important Characteristics of a Parent-Subsidiary Relationship:
Subsidiary Independence: While the subsidiary remains an independent business, the parent company wields significant authority.
Parental Power: The parent company aims to maintain control while respecting the subsidiary’s independence. Clear bylaws and regulations help achieve this balance.
Liability: Independent subsidiaries can reduce the risk of liability for the parent company. Separate board members and distinct bylaws between businesses contribute to this separation1.
Liability When an LLC Is Sued:
Filing for a parent-subsidiary relationship can protect business owners from legal claims against limited liability businesses.
An LLC (Limited Liability Company) ensures that the business remains separate from its members, preventing personal lawsuits against them.
LLC subsidiaries, entirely or majority-owned by another parent company (either an LLC or a corporation), maintain their independence.
Although the parent company oversees day-to-day activities, the subsidiary is considered an independent entity12.
In summary, while parent companies generally are not automatically liable for their subsidiaries’ actions, specific circumstances and legal relationships play a crucial role in determining liability3.
Learn more:
1. upcounsel.com
2. legalbeagle.com
3. nortonrosefulbright.com
4. bizfluent.com
5. fhnylaw.com
6. burges-salmon.com
+5 more
is a parent company liable for a subsidiary's actions?
Searching for: parent company liability for subsidiary actions
Searching for: parent company liability for subsidiary actions
Generating answers for you…
Generating answers for you…
In most cases, a parent company is not automatically liable for the actions of its subsidiaries. However, the extent of liability depends on several considerations:
Relationship Between a Company and Its Subsidiary:
The parent company’s stock ownership in the subsidiary.
Whether the parent corporation acquired a new company or purchased existing shares.
The level of independence maintained by the subsidiary.
The intentions of the parent company regarding control over board members, voting, and regulations.
Important Characteristics of a Parent-Subsidiary Relationship:
Subsidiary Independence: While the subsidiary remains an independent business, the parent company wields significant authority.
Parental Power: The parent company aims to maintain control while respecting the subsidiary’s independence. Clear bylaws and regulations help achieve this balance.
Liability: Independent subsidiaries can reduce the risk of liability for the parent company. Separate board members and distinct bylaws between businesses contribute to this separation1.
Liability When an LLC Is Sued:
Filing for a parent-subsidiary relationship can protect business owners from legal claims against limited liability businesses.
An LLC (Limited Liability Company) ensures that the business remains separate from its members, preventing personal lawsuits against them.
LLC subsidiaries, entirely or majority-owned by another parent company (either an LLC or a corporation), maintain their independence.
Although the parent company oversees day-to-day activities, the subsidiary is considered an independent entity1 .
Therefore, while there is no automatic liability, specific circumstances and legal relationships play a crucial role in determining whether a parent company is liable for its subsidiary’s actions
By the examples they gave which they stressed was examples we would get a ration based of ( x ) amount of ENZC shares held by each investor. The investor would still have his current amount of ENZC shares along with the SAGA shares that fit the ratio. They used 45m but we have since seen that number drop to 36 or 35m can't recall off the top of my head. So it makes you wonder what else they are planning. The major thing is that SAGA has the 450m in escrow to support the valuation of 10 a share. If not what is going to prop it up? It wont be the value of the two companies or we would be atleast valued at 450m giving us a current share price of .14+ if you use 3.1b as share factor.
If they can break the 2 companies out of Enzolytics that easy , why don't they just setup to do an IPO for both companies and award the same ratio of shares to current shareholders that SAGA deal would bring? Basically it would be like all of us were invested in 2 private companies and then we go public by way of IPO. If the info we have been told about the results of the past and the technology they are creating I think institutional investors and BP would love to be able to buy into an IPO if everything is like they claim. IMO GLTA
I really think the SPAC deal came along and CC thought it would be the easiest way to break the two companies out of Enzolytics and get them possibly to Nasdaq or a higher tier of trading commission. If that was to happen it would leave ENZC empty and thus lawsuits would go away and or parties would much rather resolve the issues they are having when no real value is there to fight over or sell off their shares. What is a little confusing is Rostmed was to absorb all of enzolytics debit and or shelter from the lawsuits that is what CC had stated at one time, I guess that didn't work. Hoping it will workout or a bigger move is to playout by another unknown. GLTA
They were spread out during various months and years depending on what it was related to , most of the filings are mentioned in PR's
https://finance.yahoo.com/news/enzolytics-announces-international-patent-office-103000840.html
PLANO, TX / ACCESSWIRE / December 10, 2020 / Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced the filing of a provisional patent with the U.S. Patent Office on December 9, 2020 for a treatment of Multiple Sclerosis developed by Harry Zhabilov, titled NUCLEAR PROTEINS ISOLATED FROM MAMALIAN SPINAL CORD (SCNP) IMMUNE FACTOR, S er. No. 62/123341.
Enzolytics, Inc. has an aggressive strategy to cover its intellectual property. The company has the following issued U.S. patents covering its technology relating to a peptide that has been demonstrated in clinical trials to provide anti-HIV-1 retroviral benefit in vivo 1:
U.S. Patent No. 7,479,538, issued January 20, 2009, entitled Irreversibly-Inactivated Pepsinogen Fragment and Pharmaceutical Compositions Comprising the Same for Detecting, Preventing and Treating HIV.
U.S. Patent No. 8,066,982, issued November 29, 2011, entitled Irreversibly-Inactivated Pepsinogen Fragment and Pharmaceutical Compositions Comprising the Same for Detecting, Preventing, and Treating HIV.
Enzolytics also owns a proprietary cell line producing Clone 3 anti-HIV monoclonal antibody 1. The company has pending international patent applications covering the use of any of its discovered numerous conserved Coronavirus epitopes or conserved HIV epitopes in the production of monoclonal antibodies, the production of vaccines or use in diagnostic tests for detecting the viruses in patients 2.
https://finance.yahoo.com/news/enzolytics-announces-discovery-patenting-8-130000732.html
https://finance.yahoo.com/news/enzolytics-announces-progress-development-patenting-110000381.html
its not hard to look it up GLTA
https://www.upcounsel.com/how-long-does-it-take-to-get-a-patent
https://www.goldsteinpatentlaw.com/how-long-does-it-take-to-get-patent/
https://www.jdsupra.com/legalnews/how-long-does-a-u-s-patent-or-trademark-1519666/
The average time for a patent to be granted according to WIPO in 2021 is not explicitly given by any of the web results. However, based on the data from different sources, it can be estimated that the average time for a patent to be granted is between 22 and 32 months from the filing date123. This may vary depending on the type of patent, the complexity of the invention, and the workload of the patent office and the attorney
I would like to see Chandra and CC explain themselves and the PR's they put out. As many shareholders I think would like to see it too. Chandra can response to trolls on the social media sites, yet when facts are presented they remain silent. You know atleast Chandra has read this site once and awhile responding to GF on other sites. I do not have any social media accounts but anyone that would like to post anything I have stated in the last two or three post is more than welcome to them. Yes what I have posted has been sent into the contact address of Enzolytics do I expect a response no. Do I hope to be proved wrong by ENZOLYTICS 4 million times over I do. The hype that ran to .94+ was done thru out the OTC but with statements that I have posted by the ENZOLYTICS were and have been misleading to investors.
We are exactly 20 days from the end of the SPAC timeframe, also ( remember this SPAC was not actually setup at first or second with Enzolytics as the target ), yes they could take a vote to extend , but who after 2 years no results filings late , NASDAQ delisting letters would let Barry K have more time. Without solid proof is this worth a 450m purchase and still needing a PIPE to continue something would be needed for my vote. Again hard solid test results , starting projects on time., SEC filings and audits from Enzolytics. To have partnership are great are they purely that a working relationship or a partnership that is willing to finance the hard times for the better times in the future. So far we haven't seen any of thoses big names step up in that manner. We will just use round numbers 275m each pretty sure Intel, Samsung could handle that either as partners or go it alone. Here is a section from Samsung this would suggest they want a cure to happen so why no funding? When you reread it, its more of a business transaction between them than a partnership to continue as equal profitable business relations. Enzolytics uses that partners meaning a little different when used in PRs. If they were really the one to carry Enzolytics to the finish line there would be financial backing or a buy in or total buyout, there would have been a better pathway setup in Africa to insure every ( T ) and every dot was handled correctly, every detailed needed laid out and followed to the ( T ) and on time. If the cure is held by Enzolytics would you think Samsung would want to bring it to mankind to show that they have arrived into the Biopharmaceutical world? link from where the below was taking from
https://www.prnewswire.com/news-releases/enzolytics-inc-and-samsung-biologics-announce-development-and-manufacturing-agreement-for-anti-hiv-and-anti-sars-cov-2-monoclonal-antibody-therapies-301394969.html
"Partnering with Enzolytics reinforces the value of our fully integrated, end-to-end business model, which is designed to meet the unique needs and goals of our biotech clients," said John Rim, CEO of Samsung Biologics. "We look forward to providing comprehensive services and professional support for the manufacturing of this important class of Monoclonal Antibody therapeutics for the treatment of HIV and SARS-CoV-2, helping to accelerate the process of drug development to IND filing and bring these life-saving products to patients."
"The collaboration with Samsung Biologics is a significant milestone for Enzolytics' Artificial Intelligence enabled Monoclonal Antibody Platform. We chose to partner with Samsung Biologics because of Samsung Biologics' extensive experience and expertise in developing, producing, and manufacturing Monoclonal Antibodies for Infectious Diseases and Oncology." said Dr. Gaurav Chandra, Chief Operating Officer Research and Development at Enzolytics. "This partnership marks a pivotal milestone for Enzolytics to significantly advance the clinical development of our universal, durable, broadly neutralizing Monoclonal Antibodies and reduce time to the clinic and offer the much-needed treatment for patients."
GLTA and happy trading today.
He jumped in on a few post a couple of weeks ago. nothing much but he is close if not over his 15 month wait period. Hope they all are good , Law was over on RGBP before the same lies and a RS took place. Year later and looking for 5m to invest in getting trials going. Yeah right Jim could be selling the club to 2020 and 29 they seem to beat the day in and day out low trades while others have their even lower orders passed by and unfilled, maybe they can restore the club to the hype of 2020/2021 GLTA
Yes they were ,and we were basically wrapping things up in the EU, funny how facts can comeback to haunt you. This answers some of the questions why the longs have gone silent we are tired of the BS PR they do that always is an ongoing story. Jim , Law , and the list goes on , I post what I recall to keep the board up on what they have said and what they are doing and saying 3 years later with links so it isn't IMO it is posted facts on the web from the company as they once said only trust what the company puts out. DD GLTA
The last post with the 3rd link is a true eye opener , people state they didnt give completion times or deadlines for their results to be completed should read it again. This shows nothing really over 8 months to complete and we are well past 2 years since that was written.
https://www.nasdaq.com/press-release/enzolytics-reports-progress-on-its-multiple-therapeutics-platforms-and-initiatives
Correct
https://www.accesswire.com/608642/Enzolytics-Inc-Announces-New-Board-Member-Charles-Cotropia-CEO-of-BioClonetics-Immunotherapeutics-Inc-Harry-Zhabilov-CEO-of-Enzolytics-to-Join-Board-of-BioClonetics
https://www.nasdaq.com/press-release/enzolytics-inc.-2020-year-end-update-2020-12-30
https://www.nasdaq.com/press-release/enzolytics-reports-progress-on-its-multiple-therapeutics-platforms-and-initiatives
Testing at Montana is what I was thinking of, so much to keep up with. the 3rd link has a completion time stated. Primate is out of Cal. That is on their website.
We all want this to workout , that is why we bought into it , based on what they stated not what the doctor says on ( X ) or whatever you want to call it. His posting as a company officer could comeback to bite him if this fails. I believe shareholders could have a good case about his claims, but when reading the PR from years back it is really no better IMO GLTA
But if you point out the facts, and why so many invested in Enzolytics we are bashing, for questioning the their own statements . Tells you really who has the agenda here IMO GLTA
Trying to run down the info about the primate testing in a northern state university , that goes back a few years and nolonger is on Enzolytics website. It once was but never talked about results.
https://enzolytics.com/proprietary-therapeutics/
Two good reads showing what they released in 2021 and timelines they stated. Facts are facts GLTA
https://finance.yahoo.com/news/enzolytics-reports-progress-toward-completion-113000008.html
https://finance.yahoo.com/news/enzolytics-reports-progress-multiple-therapeutics-120000770.html
threw this in , seems alot of copy paste over the years
https://www.nasdaq.com/press-release/enzolytics-inc.-engages-bts-research-to-conduct-toxicity-study-2020-12-14
https://enzolytics.com/company-news/
Just thinking out loud. With all the association and contacts Barry has wouldn't you think that they would be all over ENZC and the volume would be greater than 2-5 million a day. We know that we have flippers here that are flipping or buying million's so that accounts for half the volume. Please let me know if I missed the start of Africa trials, people are making refernce to news from Africa, unless I missed it ,it hasn't started yet. Makes you question why Harry was there in March to do preparation, and we now are in Oct? GLTA
Maybe the common thing is we need to stay away from first name ending with ( arry ) to easy to replace the first letter. GLTA
Like I have been saying Barry might have done something when he was in a structure business not run by him.On his own nothing to show for, and when you are running two companies that has shown nothing completed makes you think. SPAC have been on the downslide after having a run a few years back. Not bashing the facts are what they are. GLTA
I cant remeber which longer created SAGA board when the deal was announced , I think to get new blood, new info about forward looking and away from the BS. GLTA
yes he is on saga
I see he has posted on the new board SAGA , not much has been posted over there. GLTA
Reg as a partner could still be under the NDA that they say are in place . Questions questions hopefully the curtain will be pulled back GLTA
They have stated they will be named Scientific Holding Corporation we will see GLTA
Good luck they are all becoming micro managers with our money. Cant wait to hear who it is . aurora cannabis got beat up today if they ever down grade cannabis that will be a sector that will go crazy with access to bank financing GLTA
DYNO what platform you use trading? Etrade once taking over by Morgan S , their rules changed about same day transfer for investment. Their policy now is if you have a big board stock in your portfolio they will use that value to credit your transfer up to that value to be used for investing same day. They say they don't use OTC stocks as value, Crazy that you can have over 160k in value of a OTC stock and they don't use it for a 1k transfer without a 3 day hold. Hope that gives you or anyone else what has changed with them . GLTA
Maybe it is TTOO they had a good run and returned down to earth this past week.
It is not the SEC they need to satisfy , it is the requirements of NASDAQ they failed to meet. A signed agreement would be considered but not automatically extended, and after looking into who the agreement is with and their companies compliance record their might be questions. Or do you think one blank check company that has failed to close multiple deals over the last 23 months , has no product , investors pulling out , a deadline 30 days away and a OTC company that has a history of late filings , non audited , and a 40 year history of claiming they have a cure yet no product to market of this cure and they will bless a plan from them because they signed a combination agreement. We all want them to success , we just have questions about the information we have been given and the follow thru with results we have or haven't seen to date. The informations is all we got to go on right now so the facts are the facts .Enjoy flipping today GLTA
https://www.msn.com/en-us/money/markets/sagaliam-acquisition-gets-nasdaq-delinquency-notice/ar-AA1gMSpe#image=1
https://markets.businessinsider.com/news/stocks/sagaliam-acquisition-corp-announces-execution-of-definitive-business-combination-agreement-and-receipt-of-nasdaq-listing-delinquency-letter-1032634760
No, the SEC is not part of Nasdaq. The SEC, or the Securities and Exchange Commission, is an independent federal agency that regulates the securities markets and protects investors1. Nasdaq, or the Nasdaq Stock Market, is a national securities exchange that is owned and operated by the Nasdaq OMX Group2. Nasdaq started as a subsidiary of the National Association of Securities Dealers (NASD), now known as the Financial Industry Regulatory Authority (FINRA)3. Nasdaq was launched after the SEC urged NASD to automate the market for securities not listed on an exchange3. The SEC oversees and enforces the rules and regulations that apply to Nasdaq and other exchanges, as well as to issuers, brokers, dealers, and other market participants1. The SEC also approves or disapproves any changes to Nasdaq’s listing rules, such as the recent proposal to require race and gender disclosures in its listing rules4.
Learn more:
1. sec.gov
2. nasdaq.com
3. investopedia.com
4. cnbc.com
Has anyone heard anymore about Africa?
What we were told and what has happened are two different things. How long to clear custom for Africa, I have recieved items from the EU multiple times over the past 3 months? Not bashing just questions that should be answered by Enzolytics they stated what was a line of missteps in Africa the last reason should have been handled by now, especially if Africa wants to have a HIV drug that works.
People saying that SAGA was waiting to see results , many said and showed that the deal would expire before we saw results. Unless they did start the test but not saying they did, we are now in 2024 before a result is happening.
Like the other poster stated 40 years and no BP has stepped up for 450m. It is things we all have questioned for over a year , but we get called bashers , trying to get cheap shares, no we are asking any question a shareholder would want to know. When everything was great 2 years ago .95 oh the best CEO great communication ect ect now we have crickets and the impressions that things were going good and right around the corner, but it seems we just keep kicking the can down the road now.
We know it is a Bio company and it takes time, they are the ones that told how fast things were going to happen , Ex Africa was talked about in 2021, Clone 3 in trials, trials in EU . So I think the ones who want to call the ones basher ect are the flippers and not the holders of this stock asking for questions to be answered and yes they owe us something other that silence not every single person a personal reply but a truthful PR. GLTA
Correct which has passed now, You would think by now they would have released a PR stating we have submitted a plan to NASDAQ and waiting for approval. GLTA